Optimizing biodegradable nanoparticle size for tissue-specific delivery
- 1 November 2019
- journal article
- research article
- Published by Elsevier in Journal of Controlled Release
- Vol. 314, 92-101
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 56 references indexed in Scilit:
- PLA/PLGA nanoparticles for delivery of drugs across the blood-brain barrierNanotechnology Reviews, 2013
- Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivoGene Therapy, 2012
- Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platformProceedings of the National Academy of Sciences, 2011
- Nanoparticles Deliver Triplex-forming PNAs for Site-specific Genomic Recombination in CD34+ Human Hematopoietic ProgenitorsMolecular Therapy, 2011
- Effects of Nanoparticle Size on Cellular Uptake and Liver MRI with Polyvinylpyrrolidone-Coated Iron Oxide NanoparticlesACS Nano, 2010
- Convection-enhanced delivery of camptothecin-loaded polymer nanoparticles for treatment of intracranial tumorsDrug Delivery and Translational Research, 2010
- Targeted nanodelivery of drugs and diagnosticsNano Today, 2010
- Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNANature Materials, 2009
- Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted miceBiomaterials, 2009
- High loading efficiency and tunable release of plasmid DNA encapsulated in submicron particles fabricated from PLGA conjugated with poly-L-lysineJournal of Controlled Release, 2008